AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Mycophenolate Sodium in Kenya
4 products registered with PPB — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Myfortic Tablets 180mg Gastro-Resistant Tablet | 15967/R1 | Novartis | active | 13 Jul 2031 |
| Myfortic tablets 360mg Gastro-Resistant Tablet | 16124/R1 | Novartis | active | 13 Jul 2031 |
| Mofecon-S 180 Modified-Release Tablet | H2025/CTD8847/16864 | Concord Biotech LTD | active | 6 Oct 2030 |
| Mofecon-S 360 Tablet | H2021/CTD8166/16641 | CONCORD BIOTECH LIMITED | active | 27 Aug 2026 |
Mycophenolate Sodium — PPB Registration Details
PPB (Kenya) has 4 registered products containing Mycophenolate Sodium, of which 4 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Mycophenolate Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.